Anti-KIF21B monoclonal antibody

Pre-made anti-KIF21B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KIF21B/KIF21B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2562-Ab-1/ GM-Tg-hg-IP2562-Ab-2Anti-Human KIF21B monoclonal antibodyHuman
GM-Tg-rg-IP2562-Ab-1/ GM-Tg-rg-IP2562-Ab-2Anti-Rat KIF21B monoclonal antibodyRat
GM-Tg-mg-IP2562-Ab-1/ GM-Tg-mg-IP2562-Ab-2Anti-Mouse KIF21B monoclonal antibodyMouse
GM-Tg-cynog-IP2562-Ab-1/ GM-Tg-cynog-IP2562-Ab-2Anti-Cynomolgus/ Rhesus macaque KIF21B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2562-Ab-1/ GM-Tg-felg-IP2562-Ab-2Anti-Feline KIF21B monoclonal antibodyFeline
GM-Tg-cang-IP2562-Ab-1/ GM-Tg-cang-IP2562-Ab-2Anti-Canine KIF21B monoclonal antibodyCanine
GM-Tg-bovg-IP2562-Ab-1/ GM-Tg-bovg-IP2562-Ab-2Anti-Bovine KIF21B monoclonal antibodyBovine
GM-Tg-equg-IP2562-Ab-1/ GM-Tg-equg-IP2562-Ab-2Anti-Equine KIF21B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2562-Ab-1/ GM-Tg-hg-IP2562-Ab-2; GM-Tg-rg-IP2562-Ab-1/ GM-Tg-rg-IP2562-Ab-2;
GM-Tg-mg-IP2562-Ab-1/ GM-Tg-mg-IP2562-Ab-2; GM-Tg-cynog-IP2562-Ab-1/ GM-Tg-cynog-IP2562-Ab-2;
GM-Tg-felg-IP2562-Ab-1/ GM-Tg-felg-IP2562-Ab-2; GM-Tg-cang-IP2562-Ab-1/ GM-Tg-cang-IP2562-Ab-2;
GM-Tg-bovg-IP2562-Ab-1/ GM-Tg-bovg-IP2562-Ab-2; GM-Tg-equg-IP2562-Ab-1/ GM-Tg-equg-IP2562-Ab-2
Products NameAnti-KIF21B monoclonal antibody
Formatmab
Target NameKIF21B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KIF21B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2562-Ag-1Recombinant multi-species KI21B/ KIF21B protein


    Target information

    Target IDGM-IP2562
    Target NameKIF21B
    Gene ID23046,16565,289397,710792,490245,101098602,100337196,100063175
    Gene Symbol and Synonyms2610511N21Rik,KIF21B,mKIAA0449
    Uniprot AccessionO75037,F1M5N7
    Uniprot Entry NameKI21B_HUMAN,KI21B_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000116852
    Target ClassificationN/A

    The target: KIF21B, gene name: KIF21B, also named as . This gene encodes a member of the kinesin superfamily. Kinesins are ATP-dependent microtubule-based motor proteins that are involved in the intracellular transport of membranous organelles. Single nucleotide polymorphisms in this gene are associated with inflammatory bowel disease and multiple sclerosis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.